Top Series B Biotech companies

Companies applying biology, chemistry, and computation to therapeutics and tooling. Filtered to companies whose latest disclosed round is Series B.

Edit the query above, or pick a refinement. 500 free credits on sign-up, no card needed.

Built from a search like: “Top Series B Biotech companies”

Ranked by current headcount across Series B Biotech companies. Refreshed daily.

1
Foundation Medicine· Boston, Massachusetts, United States
Foundation Medicine is a global, patient-focused precision medicine company delivering high-quality, transformative diagnostic solutions in cancer and other diseases. We provide tests and solutions to transform care throughout a patient’s experience, from defining a diagnosis to determining the appropriate treatment to ongoing monitoring. We help accelerate the development of new personalized therapies by leveraging our vast knowledge of precision medicine, real world data and AI-powered tools, expanding the information our diagnostic solutions provide to enable improved outcomes for patients. Every day, we are inspired to think differently to transform the lives of people living with cancer and other diseases. For more information, visit us at www.FoundationMedicine.com.Community Guidelines: bit.ly/FMICommunityGuidelines
- Series B
- 1.8k employees
- Founded 2010
2
MGI· Shenzhen, Guangdong, China
MGI Tech Co., Ltd. (or its subsidiaries, together referred to as MGI) is committed to building core tools and technologies that drive innovation in life science. Our focus lies in research & development, manufacturing, and sales of instruments, reagents, and related products in the field of life science and biotechnology. We provide real-time, multi-omics, and full spectrum of digital equipment and systems for precision medicine, agriculture, healthcare and various other industries.Founded in 2016, MGI has grown into a leader in life science, serving customers across six continents and has established research, manufacturing, training, and after-sales service facilities globally. As one of the few companies capable of independently developing and mass-producing clinical-grade gene sequencers, MGl empowers global users with scalable sequencing capabilities ranging from Gb to Tb levels. MGl also stands out as one of the only providers of a full-stack product portfolio that spans three core segments: SEQ ALL (short-and long-read sequencing),GLI (Generative Lab Intelligence), and Multi-Omics.
- Series B
- 1.4k employees
- Founded 2016
3
Novogene· Xinchengzi, Beijing, China
Novogene specializes in the application of advanced molecular biotechnology and high-performance computing in the research fields of life science and human health. Established in March 2011, Novogene strives to become a global leader in providing genetic science services and technology products. Novogene has set up operations and laboratories in the United States, the United Kingdom, Netherlands, Germany, as well as in China, Singapore and Japan.Novogene currently consists of a comprehensive, and interdisciplinary team, the majority of which hold advanced degrees from top universities in China and abroad. The company has established high-flux, large-scale gene sequencing and high-performance computing platforms, which support effectively the demands of life science research and medical health for big data analysis and storage. Novogene has served over 7,300 global customers, covering 90 countries and regions across 6 continents. We have cooperated extensively with many academic institutions and completed several advanced-level, international genomics research projects. By 2023, Novogene has co-published and/or been acknowledged in more than 22,850 articles in Science Citation Index, with an accumulative impact factor of more than 148,250. Our partners are worldwide and include more than 4,200 scientfic research institutions and universities, more than 680 hospitals and over 2,400 pharmaceutical and agricultural enterprises. Currently, Novogene has obtained 356 software copyrights and 66 patents. As the leader in genome sequencing, Novogene’s business spans across scientific research for life science, medical research and technology services, storage-building sequencing platform services, gene sequencing, mass spectrometry and bio-information technology support for global research, scientific research institutions, hospitals, pharmaceutical R&D enterprises and agricultural enterprises.
- Series B
- 744 employees
- Founded 2011
Live search
This list is a starting point
I can run a natural-language search across LinkedIn, GitHub, and the open web. Fire one of these, or edit the box up top to match exactly who you're after.
- Series B Biotech companies in San FranciscoRun
- Series B Biotech companies hiringRun
500 free credits on sign-up, no card needed.
4
Sinocare Inc.· Changsha Village, Hainan, China
As a high-tech company, Sinocare Inc. has been dedicating itself to bio-sensor technology research & development, manufacturing and marketing of POCT products since its establishment in Aug,2002. Sinocare focuses intensively and extensively on the R&D of products and innovation of technology, casting our look into the future, to deliver significant benefits for people pursuing healthy living.In March, 2012, Sinocare Inc. was listed on Shenzhen Stock Exchange, abbreviated as "Sinocare" with stock code 300298. We passed ISO13485 and our products were certified by EU CE.The company's Sinocare glucometer series and its test strips has won an universal recognition from a large number of consumers thanks to its accuracy, simplicity and affordability. The product is not only popular in China, but also exports in large scale. Observing the values of “equality, honesty, innovation and excellence”, Sinocare conducts continuous innovation and establishes "portable laboratory" based on POCT product. The company aims at providing quality product and service for China’s chronic disease management, help chronic disease patients improve living quality and reduce the burden of social medical care system.
- Series B
- 586 employees
- Founded 2002
5
Isomorphic Labs· London, England, United Kingdom
Isomorphic Labs is here to advance human health by building on and beyond the Nobel-winning AlphaFold system. Our interdisciplinary team has developed a unified, state-of-the-art drug design engine that will transform how we design new drugs, and ultimately change the way medicine will help and heal people. Every day, and with each new breakthrough, we’re getting closer to achieving our ambitious mission to one day solve all disease
- Series B
- 402 employees
- Founded 2021

6
Tidal Vision· Bellingham, Washington, United States
Tidal Vision is the world leader in technologies involving chitosan extraction, modification, formulation and application. Tidal Vision is working to unlock scalable chitosan biomolecular solutions for humanity’s greatest chemistry and pollution challenges in the water treatment, agriculture, and material industries. Tidal Vision is composed of the following commercial divisions: Tidal Clear®, Clear Water ServicesTM, Tidal Grow®, and Tidal-Tec®. Tidal Clear offers a chitosan-based product line of powerful turnkey biopolymer coagulants & flocculants. Clear Water Services specializes in applying Tidal Clear, and offers innovative mobile and modular water treatment solutions utilizing a comprehensive data-backed approach. With industry-leading automation, built-to-order filtration components, and locations across the country, Clear Water Services provides a network of equipment and services to tackle evolving water quality and emerging contaminant issues from coast to coast.Tidal Grow is Tidal Vision’s agriculture division. By leveraging novel technologies, their offerings deliver new levels of effectiveness in plant nutrition and crop protection, providing impressive ROI for growers. With their Tidal Grow® Integra Technology, they engineer how fertilizer, such as nitrogen, and crop protection products are delivered to the crop. The Tidal Grow® Bioactive product portfolio harnesses the power of nature to create effective plant nutrition and crop protection products. Tidal Grow® increases crop input effectiveness to deliver more yield per unit applied.Tidal-Tec was formed in response to the growing global appetite for safer materials that benefit both humanity and the planet. This division’s cutting edge biomolecular technologies deliver consistent and scalable performance solutions for pressing challenges throughout material science. Tidal-Tec is uniquely built for partnering with leading materials companies who want the next generation performance materials.
- Series B
- 382 employees
- Founded 2015
7
BostonGene· Waltham, Massachusetts, United States
BostonGene is redefining cancer patient care and drug development through the integration of omnimodal data and AI. Built and validated across an extensive real-world clinical network, BostonGene’s foundation model of cancer and the immune system integrates genomic, transcriptomic, immune, and clinical outcome data to map the complexities of the tumor microenvironment and generate biologically grounded, actionable insights. These insights enable biopharma partners to accelerate discovery timelines, de-risk clinical trials, identify novel targets, and optimize therapeutic responses across all stages of development, while also advancing clinically integrated patient care. BostonGene has established unrivaled credibility across oncology and immunology through a collaborative ecosystem of deep academic partnerships with MD Anderson Cancer Center, Memorial Sloan Kettering, Dana Farber Cancer Institute, the Mayo Clinic, and other leading cancer institutions across the globe. These are complemented by strategic business partnerships with AstraZeneca, Johnson & Johnson, Takeda, Ottimo Pharma, and other global pharma and biotech leaders leveraging BostonGene’s platform to drive precision medicine. Its work is reflected in more than 200 publications in top peer-reviewed journals, including Nature, Cancer Cell, and Cancer Discovery. The company's industry-leading innovation has been recognized with awards such as Frost & Sullivan’s 2025 Global Technology Innovation Leadership Award in AI-driven Precision Oncology Solutions, as well as BioTech Breakthrough’s 2025 Overall Immunology Company of the Year and 2025 AI-based Drug Discovery Solution of the Year.
- Series B
- 369 employees
- Founded 2015
8
4baseCare· Bengaluru, Karnataka, India
4baseCare, an Illumina-backed Company* headquartered in Singapore, is engaged in developing cutting-edge Precision Oncology Solutions using Advanced Genomics and Next-Gen digital health technology. Taking into consideration that the clinical outcome could significantly vary across different populations, we have developed a unique set of indigenous comprehensive cancer gene panels that enables oncologists to choose the optimal precision therapies for their patients.Our coveted 🧬genomic testing portfolio assesses the tumour genomic alterations by NGS from Tissue or Liquid biopsy for Somatic Mutation Analysis and Germline Mutation Testing for Hereditary and Familial Cancer from peripheral blood to personalize patient care in Oncology.4baseCare is backed by a highly experienced Advisory board who are leaders in genomics and technology. Among them is Lip Bu Tan, Chairman of Walden International and advisor to Yali Capital, which has invested in 4baseCare. Also on the board is Francis deSouza, a Silicon Valley tech veteran and former CEO of Illumina, who brings over 30 years of expertise in genomics, technology, and healthcare. Milestones - 4baseCare’s journey has been marked by significant milestones in both funding and growth. The company has raised $6 Million in Series A funding led by Yali Capital with participation from Mathew Cyriac. In March 2021, 4baseCare had raised $2 Million in led by Mount Judi Ventures, growX ventures, Season Two Ventures, First In Ventures, and other angel investors. 4baseCare’s test has made a significant impact in Southeast Asia, with over 10,000 cancer patients taking the test. 4baseCare has collaborations with more than 300 oncologists in India. This growing network with oncologists and leading hospitals in India ensures that more patients are able to opt for personalized cancer care.
- Series B
- 322 employees
- Founded 2018
9
hVIVO· London, England, United Kingdom
hVIVO plc (Ticker: HVO) is a science‐led early‐phase drug development company purpose‐built to meet the growing complexity of modern clinical research. The Company operates an integrated early‐phase ecosystem that combines specialist clinical sites, advanced virology and immunology laboratories, human challenge expertise, and early drug development consulting. This unified model enables sponsors to generate rigorous, decision‐ready human data earlier in development, reducing uncertainty and accelerating progression through Phase I and II trials.With industry‐leading capabilities in respiratory and infectious disease, alongside expanding expertise in cardiometabolic and other high‐growth therapeutic areas, hVIVO supports a diverse global client base that includes seven of the world’s ten largest biopharmaceutical companies. Its London quarantine facilities are the largest purpose‐built human challenge units in the world, complemented by additional early‐phase clinical capacity in Germany and a specialist consulting team providing strategic, regulatory, and biometry expertise.The Company’s integrated approach delivers a seamless pathway from preclinical planning through early proof‐of‐concept, supported by continuous patient recruitment through FluCamp and a network of outpatient clinical sites for Phase II and III studies. By unifying scientific insight, operational control, and advanced laboratory capabilities, hVIVO provides sponsors with the clarity, speed, and reliability required to advance new medicines with confidence.
- Series B
- 236 employees
- Founded 1989
10
Kardigan· Princeton, New Jersey, United States
Kardigan is a patient-driven heart health company that is modernizing cardiovascular drug development to deliver medicines that move patients beyond symptom management to functional cures. By matching critical disease drivers with treatment responders identified in clinical trials, Kardigan is developing a portfolio of medicines that modify the underlying cardiovascular disease pathophysiology to get patients closer to the cures they deserve. Kardigan has significant East and West Coast operations and focus. For more information about Kardigan, please visit kardigan.bio. If you are interested in joining our passionate and driven team with deep cardiovascular, biotechnology and operational expertise, please visit kardigan.bio or the careers tab of this page.
- Series B
- 203 employees
- Founded 2023

Reveal 539 more·500 free credits, no card

Find engineers and founders at Series B Biotech companies

Series B Biotech companies are some of the most active hirers in the market. The list above ranks the largest Biotech companies whose latest disclosed round is Series B, by current headcount, drawn from public LinkedIn and Crunchbase records. Across 544 matching companies, you’ll find senior engineers, founding designers, and operators worth tracking.

Companies at this stage in Biotech share a profile: a working product, fresh capital, and a hiring plan that wants senior people yesterday. Looking at headcount, last round, and HQ side by side gives you a quick read on where Biotech talent is concentrating right now.

Refolk converts this list into a search. Ask for “Series B Biotech founders hiring senior engineers” or “design leads at Series B Biotech companies” and Refolk returns a fresh ranked shortlist with the sources behind each match.

How this list is built

Refolk pulled Biotech companies whose latest disclosed funding round is Series B from public LinkedIn and Crunchbase records, ranked them by current employee count, and kept those with at least 5 employees. The list refreshes once a day.

Last refreshed: Wed, 05 Aug 2026 16:02:51 GMT

Search this list

Need an even more specific search?

Refolk runs natural-language searches across LinkedIn, GitHub, and the open web. Try one of these:

500 free credits on sign-up, no card needed.

Related lists

See all company lists.

Or zoom out

Slice this list a different way

Common questions

How is this ranking built?

The list draws on the public company graph - headcount and growth signals, funding history, and recency. The criteria chips at the top show exactly which filters produced it, and the methodology section explains the ranking.

How fresh is the data?

The underlying index updates continuously and this page re-renders at least daily. Last refreshed: Wed, 05 Aug 2026 16:02:51 GMT.

Can I get the full list of 544 companies?

Yes. This page shows the top of the ranking; sign up and I'll run the search live for the complete, current list. You start with 500 free credits, no card required.

Can I find the people inside these companies?

Yes. Ask in plain English - for example "engineering leaders at these companies who joined in the last year" - and I return the specific people, with context on each.

Try it on your own search

Stop building boolean strings. Just describe the person.

Type one sentence and I plan the search, read GitHub, public LinkedIn and Crunchbase records, and the open web live, then hand back a ranked shortlist with the reasoning behind every name. No filters to learn, no export to clean up, no sales call to sit through.

One sentence in, a ranked shortlist out. No boolean, no filters, no seat to buy.
Read live at search time, not from a database that went stale last quarter.
Watch every step as it runs, and see why each name made the list.

500 free credits on sign-up. No card, no demo call. See real searches.

This list is a starting point